2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Epion Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment - Keratoconus | Phase 3 | Completed | Epion Therapeutics | 398 | 2023-11-01 | 2026-06-25 |
| Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment - Keratoconus | Phase 3 | Completed | Epion Therapeutics | 396 | 2023-10-30 | 2026-06-25 |
Keratoconus (2)
Riboflavin (2)
United States (2)